These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5252300)

  • 41. [Regularities in the change in leukocyte count during treatment of chronic myeloid leukosis].
    Emanuél' NM; Sherman SI; Levitin EI; Rozanova LM; Evseenko LS; Kukharenko IuA
    Dokl Akad Nauk SSSR; 1967 Aug; 175(5):1197-200. PubMed ID: 5270825
    [No Abstract]   [Full Text] [Related]  

  • 42. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
    Martino R; Pérez-Simón JA; Moreno E; Queraltó JM; Caballero D; Mateos M; Sureda A; Cañizo C; Brunet S; Briones J; Vazquez L; Clopés A; San Miguel JF; Sierra J
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):437-47. PubMed ID: 15931632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aplastic syndrome in myleran overdose].
    Albrecht M; Tackmann W; Pribilla W
    Med Klin; 1971 Jan; 66(4):126-30. PubMed ID: 5278287
    [No Abstract]   [Full Text] [Related]  

  • 44. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current therapy problems in chronic myeloleukosis].
    Faĭnshteĭn FE; Khoroshko ND
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):3-7. PubMed ID: 7015319
    [No Abstract]   [Full Text] [Related]  

  • 46. Blastic crisis of chronic myelogenous leukaemia.
    Koza I; Cerný V; Bohunický L; Hal'ko J; Ujházy V; Petrek C; Krizan Z
    Neoplasma; 1969; 16(4):417-26. PubMed ID: 5259327
    [No Abstract]   [Full Text] [Related]  

  • 47. [A modern therapeutic strategy in Ph-positive chronic myeloleukemia].
    Khoroshko ND; Turkina AG; Zhuravlev VS; Sokolova MA; Mikhaĭlova IN; Zakharova AV; Domracheva EV; Semenova EA
    Ter Arkh; 1996; 68(7):22-7. PubMed ID: 8928067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recent developments in the treatment of chronic myeloid leukemia].
    Herrmann R
    Med Klin; 1980 Aug; 75(18):645-9. PubMed ID: 6106883
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
    Volkova SA; Prytkova MV; Borovkov NN
    Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 51. [Chronic myeloleukosis].
    Markarian VG
    Med Sestra; 1977 Aug; 36(8):44-6. PubMed ID: 271756
    [No Abstract]   [Full Text] [Related]  

  • 52. Hydroxyurea therapy in chronic myeloid leukemia.
    Agarwal MB; Mehta BC
    J Assoc Physicians India; 1982 Jul; 30(7):427-8. PubMed ID: 6963266
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of busulphan non-responsive chronic myeloid leukaemia.
    Roul RK; Singh AD
    J Indian Med Assoc; 1982 Aug; 79(3):27-9. PubMed ID: 6960081
    [No Abstract]   [Full Text] [Related]  

  • 54. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preliminary results of myelobromol treatment of chronic granulocytic leukemia].
    Urasiński I; Mysik M
    Wiad Lek; 1971 Jul; 24(3):271-4. PubMed ID: 5279032
    [No Abstract]   [Full Text] [Related]  

  • 56. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
    Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination chemotherapy for chronic granulocytic leukaemia.
    Allan NC; Duvall E; Stockdill G
    Lancet; 1978 Sep; 2(8088):523. PubMed ID: 79887
    [No Abstract]   [Full Text] [Related]  

  • 58. Cytogenetic anomalies in a child born to a mother receiving busulfan for chronic myeloid leukaemia.
    Bhisey AN; Advani SH; Khare AG
    Indian J Cancer; 1982; 19(5):272-6. PubMed ID: 6219940
    [No Abstract]   [Full Text] [Related]  

  • 59. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
    Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
    Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.